| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | Mirtazapine+Normirtazapine | LP112411-6 |
| PROPERTY | MCnc | LP6827-2 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | Mirtazapine+Normirtazapine | Serum or Plasma | Drug toxicology | LP391076-9 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | ug/L | |
| EXAMPLE_UCUM_UNITS | ug/L | |
| UNITSREQUIRED | N |
| LONG_COMMON_NAME | en-US | Mirtazapine+Normirtazapine [Mass/volume] in Serum or Plasma |
| LONG_COMMON_NAME | en-US | Mirtazapine+Normirtazapine [Mass/volume] in Serum or Plasma |
| SHORTNAME | en-US | Mirtazapine+Normirtazapine SerPl-mCnc |
| ConsumerName | en-US | Mirtazapine+Normirtazapine, Blood |
| LONG_COMMON_NAME | fr-FR | Mirtazapine+normirtazapine [Masse/Volume] Sérum/Plasma ; Numérique |
| LONG_COMMON_NAME | nl-NL | Mirtazapine + normirtazapine [massa/volume] in serum of plasma |
| LONG_COMMON_NAME | es-MX | Mirtazapina + Normirtazapina: Suero o Plasma : Punto temporal: Concentración de masa: Cuantitativo: |
LOINC Version: 2.80
FHIR